Colorectal Cancer Clinical Trials in Boston

Showing 21-40 of 268 trials

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

NCT07128355

This is a single-arm pilot feasibility study evaluating the combination of Botensilimab and Balstilimab with Radiation Therapy (RT) in Non-Microsatellite Instability High (MSI-H) or Proficient Mismatch Repair (pMMR) chemorefractory colorectal cancer (CRC) with liver metastasis.

Non-MSI-H or pMMR Colorectal Cancer With Liver Metastasis

Massachusetts General Hospital15 participantsStarted Jun 2026

Boston, Massachusetts, United States

RECRUITINGNA< 1 mile

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Breast Cancer, NOSCNS Primary Tumor, NOSCervical Cancer, NOS+9 more

Eastern Cooperative Oncology Group400 participantsStarted Nov 2021

Fairbanks, Alaska, United States • Kingman, Arizona, United States • Phoenix, Arizona, United States +344 more locations

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Colorectal Cancer Trials in Other Cities

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Resilience and Equity in Aging, Cancer, and Health (REACH)

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

GCC19CART for Patients With Metastatic Colorectal Cancer

Video Education With Result Dependent dIsclosure

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer

SafeHeal Diverting Ileostomy Pivotal Study

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Other Conditions in Boston